Allergy Service, Infanta Leonor Hospital, Madrid, Spain.
Clin Exp Allergy. 2013 Jan;43(1):85-91. doi: 10.1111/cea.12013.
Multiple Non-steroidal anti-inflammatory drugs (NSAID)-induced urticaria/angioedema is the most common manifestation of hypersensitivity reactions to NSAIDs. Diagnostic evaluation is based on the clinical history and a drug provocation test.
To evaluate the role of the clinical history in the diagnosis of multiple NSAID-induced urticaria/angioedema.
We studied a group of patients with an unequivocal history of urticaria and/or angioedema after NSAID intake. Subjects had to have had at least two episodes of cutaneous symptoms with two different COX-1 inhibitors. The diagnosis was confirmed in all cases by a drug provocation test with acetyl salicylic acid (ASA). Multivariate analysis was done by analysing different variables, including number of drugs involved, episodes and time elapsed between drug intake and symptom onset.
Of the total group of 75 cases with multiple NSAID-induced urticaria/angioedema diagnosed according to the clinical history, 76% developed a positive drug provocation test with ASA. The risk for having hypersensitivity was 17 times higher in patients who developed symptoms within the first 60 min after drug intake, 13 times higher in those who experienced reactions with more than two non-chemically related NSAIDs, and 10 times higher in women.
Drug provocation testing with ASA confirms the diagnosis of multiple NSAID-induced urticaria/angioedema in up to 92% of cases with an unequivocal clinical history, when reactions occur within 1 h and more than two different NSAIDs are involved.
多种非甾体抗炎药(NSAID)诱导的荨麻疹/血管性水肿是 NSAIDs 过敏反应最常见的表现。诊断评估基于临床病史和药物激发试验。
评估临床病史在诊断多种 NSAID 诱导的荨麻疹/血管性水肿中的作用。
我们研究了一组明确有 NSAID 摄入后荨麻疹和/或血管性水肿病史的患者。患者必须至少有两次不同 COX-1 抑制剂的皮肤症状发作。在所有病例中,均通过乙酰水杨酸(ASA)药物激发试验确诊。通过分析不同变量(包括涉及的药物数量、发作次数和药物摄入与症状出现之间的时间间隔)进行多变量分析。
根据临床病史诊断的 75 例多种 NSAID 诱导的荨麻疹/血管性水肿患者中,76%对 ASA 药物激发试验呈阳性。在药物摄入后 60 分钟内出现症状的患者发生过敏的风险高 17 倍,出现反应的非甾体抗炎药多于两种且无化学相关性的患者高 13 倍,女性高 10 倍。
当反应发生在 1 小时内且涉及两种以上不同的 NSAID 时,用 ASA 进行药物激发试验可在 92%具有明确临床病史的情况下确认多种 NSAID 诱导的荨麻疹/血管性水肿的诊断。